Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Matrices
Patent
1996-12-27
1998-12-01
Nutter, Nathan M.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Matrices
424485, 424486, 424488, 424489, 424464, 424468, 424469, 424470, 514812, A61K 914
Patent
active
058434801
ABSTRACT:
A controlled-release pharmaceutical preparation comprising diamorphine, or a pharmaceutically acceptable salt thereof.
REFERENCES:
patent: 2738303 (1956-03-01), Blythe et al.
patent: 3065143 (1962-11-01), Christenson et al.
patent: 3652589 (1972-03-01), Flick et al.
patent: 3830934 (1974-08-01), Flick et al.
patent: 3845770 (1974-11-01), Theeuwes et al.
patent: 3950508 (1976-04-01), Mony et al.
patent: 3965256 (1976-06-01), Leslie
patent: 3974157 (1976-08-01), Shetty et al.
patent: 4013784 (1977-03-01), Speiser
patent: 4076798 (1978-02-01), Casey et al.
patent: 4132753 (1979-01-01), Blichare et al.
patent: 4259314 (1981-03-01), Lowey
patent: 4343789 (1982-08-01), Kawata et al.
patent: 4366172 (1982-12-01), Lednicer
patent: 4380534 (1983-04-01), Fukui et al.
patent: 4389393 (1983-06-01), Schor et al.
patent: 4421736 (1983-12-01), Walters
patent: 4483847 (1984-11-01), Augart
patent: 4533562 (1985-08-01), Ikegami et al.
patent: 4600645 (1986-07-01), Ghebre-Sellassie et al.
patent: 4613619 (1986-09-01), Sleigh et al.
patent: 4621114 (1986-11-01), Watanabe
patent: 4728513 (1988-03-01), Ventouras
patent: 4797410 (1989-01-01), El-Fakahany
patent: 4801458 (1989-01-01), Hidaka et al.
patent: 4801460 (1989-01-01), Goertz et al.
patent: 4828836 (1989-05-01), Elger et al.
patent: 4834984 (1989-05-01), Goldie et al.
patent: 4834985 (1989-05-01), Elger et al.
patent: 4844907 (1989-07-01), Elger et al.
patent: 4844909 (1989-07-01), Goldie et al.
patent: 4861598 (1989-08-01), Oshlack
patent: 4880830 (1989-11-01), Rhodes
patent: 4894234 (1990-01-01), Sharma et al.
patent: 4917899 (1990-04-01), Geoghegan et al.
patent: 4925675 (1990-05-01), Giannnini et al.
patent: 4935246 (1990-06-01), Ahrens
patent: 4970075 (1990-11-01), Oshlack
patent: 4987136 (1991-01-01), Kreek et al.
patent: 4990341 (1991-02-01), Goldie et al.
patent: 5007790 (1991-04-01), Shell
patent: 5019397 (1991-05-01), Wong et al.
patent: 5023089 (1991-06-01), Sakamoto et al.
patent: 5024842 (1991-06-01), Edgren et al.
patent: 5026560 (1991-06-01), Makino et al.
patent: 5030400 (1991-07-01), Danielsen et al.
patent: 5068110 (1991-11-01), Fawzi et al.
patent: 5071646 (1991-12-01), Malkowska et al.
patent: 5073379 (1991-12-01), Klimesh et al.
patent: 5126145 (1992-06-01), Evenstad et al.
patent: 5132142 (1992-07-01), Jones et al.
patent: 5133974 (1992-07-01), Paradissis et al.
patent: 5162117 (1992-11-01), Stupak et al.
patent: 5167964 (1992-12-01), Muhammed et al.
patent: 5169645 (1992-12-01), Shukla et al.
patent: 5178868 (1993-01-01), Malmqvist-Granlund et al.
patent: 5196203 (1993-03-01), Boehm
patent: 5202128 (1993-04-01), Morella et al.
patent: 5204119 (1993-04-01), Shiobara et al.
patent: 5266331 (1993-11-01), Oshlack et al.
patent: 5271934 (1993-12-01), Goldenberg et al.
patent: 5273760 (1993-12-01), Oshlack et al.
patent: 5286493 (1994-02-01), Oshlack et al.
patent: 5292461 (1994-03-01), Juch et al.
patent: 5300300 (1994-04-01), Egidio et al.
patent: 5321012 (1994-06-01), Mayer et al.
patent: 5330766 (1994-07-01), Morella et al.
patent: 5378474 (1995-01-01), Morella et al.
patent: 5395626 (1995-03-01), Kotwal et al.
patent: 5403493 (1995-04-01), Mouche et al.
patent: 5403593 (1995-04-01), Royce
patent: 5443846 (1995-08-01), Yoshioka et al.
patent: 5453283 (1995-09-01), Munch et al.
patent: 5472710 (1995-12-01), Klokkers-Bethke et al.
patent: 5478577 (1995-12-01), Suchler et al.
patent: 5500227 (1996-03-01), Oshlack et al.
patent: 5549912 (1996-08-01), Oshlack et al.
patent: 5591452 (1997-01-01), Miller et al.
Carter, S.J., et al., "Long-Acting Oral Medicaments", Pharmacy Digest, pp. 183-189, Apr. 1961.
Japanese Patent Publication No. 43 (1968) 20006 "Detailed Description of the Invention".
Bloomfield, et al., "Clinical Trials and Therapeutics--Analgesic efficacy and potency of two oral controlled-release morphine preparations", Clinical Pharmacology & Therapeutics, vol. 53, No. 4, pp. 469-478, Apr. 1993.
(Abstracts), 7th World Congress on Pain, Thursday, Aug. 26, 1993, Abstract Nos. 997-1001.
Multi-dose randomized crossover trial demonstrates Roxanol SR and MS Contin are bioequivalent, 1988 Roxane Laboratories, Inc.
Hunt, Thomas L., M.D., Ph.D., et al., "Comparison of the Pharmacokinetic Profiles of Two Oral Controlled-Release Morphine Formulations in Healthy Young Adults", Clinical Therapeutics, vol. 13, No. 4, pp. 482-488, 1991.
Thomsen, L., Juul, et al., "Prolonged Release Matrix Pellets Prepared by Melt Pelletization II. Hydrophobic Substances as Meltable Binders", Drug Development and Industrial Pharmacy, vol. 20, No. 7, pp. 1179-1197 (1994).
Thomsen, L., Juul, "Utilizing melt pelletization technique for the preparation of prolonged release products", Pelletization, (material elaborated by assistant prof. Lars Juul Thomsen, Department of Pharmaceutics, Royal Danish School of Pharmacy for the DIE course Pelletization Technology, Nov. 1992, 106 pages plus 3 appendices.
Thomsen, L. Juul, "Prolonged Release Matrix Pellets Prepared by Melt Pelletization. Part IV: Drug Conent, Drug Particle Size, and Binder Composition", Pharmaceutical Technology Europa, pp. 19-22 (Oct. 1994).
Thomsen, L. Juul, et al., "Prolonged Release Matrix Pellets Prepared by Melt Pelletization I. Process Variables", Drug Development and Industrial Pharmacy, vol. 19, No. 15, pp. 1867-1887 (1993).
El-Shanaway, S., "Sustained Release of Nitrofurantoin From Inert Wax Matrixes", J. Controlled Release, vol. 26, vol. 1, Issued 1993, pp. 11-19.
Flanders, P., et al., "The Control of Drug Release From Conventional Melt Granulation Matrices", Drug Development and Industrial Pharmacy, vol. 13, No. 6, pp. 1001-1022 (1987).
McTaggart, C.M., et al., "The Evaluation of Formulation and Processing Conditions of a Melt Granulation Process", Int. J. Pharm., vol. 29, No. 2,Issued 1984, pp. 139-146.
Schaefer, T., et al., "Melt granulation in a laboratory scale high shear mixer", Drug Development and Industrial Pharmacy, vol. 16, No. 8, pp. 1249-1277 (1990).
M. J. Jozwiakowski et al., "Characterization of a Hot-Melt Fluid Bed Coating Process for Fine Granules", Pharm. Resear., vol. 7, No. 11, 1990, pp. 1119-1124.
M. Niskanen et al., "Pelletization in a Centrifugal Granulator, Part I: Effects of Binder-Solution Concentration", Pharm. Tech. Int'l, Oct. 1990, pp. 22-38.
L. Lachman et al., "The Theory and Practice of Industrial Pharmacy", p. 315, Lea & Febiger, Phi. 1976.
FDA Guide to Inspections of Oral Solid Dosage Forms Pre/Post Approval Issues for Development and Validation, Jan. 1994.
T. Schaefer et al. "Melt Pelletization in a High Shear Mixer I Effects of Process variables and Binder", Acta Pharm. Nord. vol. 4, No.3, pp. 133-140, 1992.
T. Schaefer et al. "Melt Pelletization in a High Shear Mixer II Power Consumption and Granule Growth", Acta Pharm. Nord. vol. 4, No.3, pp. 141-148, 1992.
T. Schaefer, et al., "Melt Granulation in a Laboratory Scale High Shear Mixer", Drug Dev. and Indust. Phar., vol. 16, No. 8, pp. 1249-1277, 1990.
McTaggart, C.M. et al., "The Evaluation of Formulation and Processing Conditions of a Melt Granulation Process", Int'l. J. Pharm., vol. 19, No. 2, issued 1984, pp. 139-148.
El-Shanawany, S., "Sustained Release of Nitrofuration From Inert Wax Matrixes", J. Controlled Release, vol. 26, No. 1, issued 1993, pp. 11-19.
P. Flanders, et al., "The Controlled of Drug Releases From Conventional Melt Granulation Matrices", Drug Dev. and Industrial Pharm., vol. 13, No. 6, pp. 1001-1022, 1987.
Thomson, I. Juul, "Matrix Pellets Prolonged Formulations Prepared by Melt Pelletization", Dept. of Pharm. Royal Danish School of Pharmacy, 1992.
Thomsen, L. Juul, et al., "Prolonged Release Matrix Pellets Prepared by Melt Pelletization II. Hydrophobic Substances as Meltable Binders", Drug Development and Industrial Pharmacy, vol. 20, No. 7, pp. 1179-1197 (1994).
G.M. Crass et al., "Sustained and Controlled Release Drug Delivery Systems", Modern Pharmaceutics, 2nd Edition, pp. 635-671, 1990.
N. Follonier et al., "Evaluation of Hot-Melt Extrusion as a New Technique for the Production of Polymer-Based Pellets for Sustained Release Capsules Containng High Loadings of Freely
Knott Trevor John
Leslie Stewart Thomas
Miller Ronald Brown
Mohammad Hassan
Prater Derek Allan
Euro-Celtique S.A.
Nutter Nathan M.
LandOfFree
Controlled release diamorphine formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Controlled release diamorphine formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled release diamorphine formulation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2393639